In the discussions and debates around the optimal breast cancer screening strategies, overdiagnosis and overtreatment concerns loom large. Now, a study published in JAMA Oncology might be cause to reevaluate the detection and treatment of ductal carcinoma in situ (DCIS), or stage 0 cancer.